Evidence mapPaperPMID 39999070Full record

SynthesisPloS one2025

Fetal genetic factors in pregnancy loss: Insights from a meta-analysis and effectiveness of whole exome sequencing.

Andrea Hadjipanteli, Athina Theodosiou, Ioannis Papaevripidou, Angelos Alexandrou, Nicole Salameh, Paola Evangelidou, Marios Tomazou, Andreas Mavrides, Sozos Fasouliotis, George Anastasiou and 15 more

Abstract readMeta-Analysis
In one paragraph

Synthesis in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Andrea HadjipanteliThe Cyprus Institute of Neurology and Genetics, Cytogenetics and Genomics, Nicosia, Cyprus.
Athina TheodosiouThe Cyprus Institute of Neurology and Genetics, Cytogenetics and Genomics, Nicosia, Cyprus.ORCID https://orcid.org/0000-0003-4363-8162
Ioannis PapaevripidouThe Cyprus Institute of Neurology and Genetics, Cytogenetics and Genomics, Nicosia, Cyprus.
Angelos AlexandrouThe Cyprus Institute of Neurology and Genetics, Cytogenetics and Genomics, Nicosia, Cyprus.
Nicole SalamehThe Cyprus Institute of Neurology and Genetics, Cytogenetics and Genomics, Nicosia, Cyprus.
Paola EvangelidouThe Cyprus Institute of Neurology and Genetics, Cytogenetics and Genomics, Nicosia, Cyprus.ORCID https://orcid.org/0000-0001-5565-0666
Marios TomazouThe Cyprus Institute of Neurology and Genetics, Cytogenetics and Genomics, Nicosia, Cyprus.ORCID https://orcid.org/0000-0002-0836-5579
Andreas MavridesISIS Clinic, Nicosia, Cyprus.
Sozos FasouliotisISIS Clinic, Nicosia, Cyprus.
George AnastasiouMother and Child Medical Centre, Nicosia, Cyprus.
Andreas StavroulisAmerican Medical Center, Nicosia, Cyprus.
Niki AgathokleousLimassol Clinic, Limassol, Cyprus.
Maria AgathokleousThe Fetal Medicine Center Ltd., Limassol, Cyprus.
Stelios TsangaridesLedra Clinic, Nicosia, Cyprus.
Ioannis KallikasAAK Ultrasound and Fetal Medicine Centre, Nicosia, Cyprus.
Kyriakos KakoullisApollonion Private Hospital, Nicosia, Cyprus.
Sofia FrakalaLedra Clinic, Nicosia, Cyprus.
Christina OxinouChristina Oxinou Histopathology/Cytology Laboratory, Nicosia, Cyprus.
Andreas MarneridesGuy's and St Thomas' NHS Foundation Trust, London, UK.
Emilia AthanasiouArchbishop Makarios III Hospital, Nicosia, Cyprus.
Sofia OuraniArchbishop Makarios III Hospital, Nicosia, Cyprus.
Violetta C AnastasiadouKaraiskakio Foundation, Nicosia, Cyprus.
George TantelesThe Cyprus Institute of Neurology and Genetics, Cytogenetics and Genomics, Nicosia, Cyprus.
Ludmila KousoulidouThe Cyprus Institute of Neurology and Genetics, Cytogenetics and Genomics, Nicosia, Cyprus.
Carolina SismaniThe Cyprus Institute of Neurology and Genetics, Cytogenetics and Genomics, Nicosia, Cyprus.ORCID https://orcid.org/0000-0002-9296-8347

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Spontaneous pregnancy loss commonly occurs during the first trimester and can be caused by various factors including chromosomal abnormalities and submicroscopic aberrations. After the first trimester, the etiology of most pregnancy losses remains undetermined. This study aims to fill this gap by an in-depth investigation of the fetal genome and its effect on pregnancy outcome. Data from 1016 spontaneously aborted fetuses previously referred for genetic testing (2017-2023) were used for meta-analysis. Fetuses were categorized based on gestational age and genetic test result. Additionally, 35 second-third trimester fetuses, that were spontaneously aborted, terminated or died neonatally, with abnormal ultrasounds and unrevealing routine genetic testing were collected. Trio-based whole-exome sequencing was performed for identification of fetal variants that may have caused the pregnancy loss. The meta-analysis revealed that 822 of 1016 fetuses (80.91%) were aborted during the first trimester, with 569 of 822 (69.22%) successfully diagnosed using conventional genetic testing. The remaining 194 fetuses (19.09%) were aborted during the second-third trimester. Of the 194 second-third trimester aborted fetuses, 163 (84.02%) lacked genetic diagnosis using conventional testing (karyotype and array-CGH). Aneuploidies were the leading cause of spontaneous pregnancy loss in both first and second-third trimester fetuses followed by polyploidies. Thus, the meta-analysis demonstrated that undiagnosed second-third trimester pregnancy losses are more likely to benefit from further genetic investigation. Application of whole exome sequencing on second-third trimester pregnancy losses, revealed causative variants in 6 of 33 families (18.18%), in genes linked to Mendelian disorders associated with the phenotypes of interest. Pathogenic findings were identified in two additional families in heterozygosity in genes following autosomal recessive inheritance. Accurate identification of variants in such genes creates new genotype-in utero phenotype associations, with the prospect of new additions in preconception/prenatal diagnostic panels. This study highlights the importance of whole exome sequencing in resolving undiagnosed pregnancy losses.

Indexed as

Abortion, SpontaneousExome SequencingFetusAneuploidyFemaleGenetic TestingHumansPregnancyPregnancy OutcomePregnancy Trimester, First

Identifiers

PMID39999070
PMCPMC11856309

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.